Alumis (ALMS) Tax Provisions (2024 - 2026)
Alumis (ALMS) posted quarterly Tax Provisions of -$39000.0 for Q4 2025, up 99.94% year-over-year from -$19506.2 in Q4 2024, and up 99.54% quarter-over-quarter from -$8.6 million in Q2 2025.
Alumis (ALMS) Tax Provisions (2024 - 2026) Analysis & Trends
Alumis (ALMS) has reported Tax Provisions for 2 consecutive years, with -$39000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions rose 99.94% year-over-year to -$39000.0; the TTM figure through Dec 2025 stood at -$70.4 million (changed N/A YoY), while the FY2025 annual figure was -$8.6 million, up 86.08% from the prior year.
- Tax Provisions climbed to -$39000.0 in Q4 2025 per ALMS's latest filing, from -$8.6 million in the prior quarter.
- Across five years, Tax Provisions topped out at -$39000.0 in Q4 2025 and bottomed at -$61.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | -1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80 Mn |
| Dec 31, 2025 | -39,000.00 |
| Jun 30, 2025 | -8.56 Mn |
| Dec 31, 2024 | -61.79 Mn |